96 related articles for article (PubMed ID: 16818366)
1. Ex vivo programming of antigen-presenting B lymphocytes: considerations on DNA uptake and cell activation.
Wheeler M; Cortez-Gonzalez X; Frazzi R; Zanetti M
Int Rev Immunol; 2006; 25(3-4):83-97. PubMed ID: 16818366
[TBL] [Abstract][Full Text] [Related]
2. TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines.
Ishii KJ; Kawagoe T; Koyama S; Matsui K; Kumar H; Kawai T; Uematsu S; Takeuchi O; Takeshita F; Coban C; Akira S
Nature; 2008 Feb; 451(7179):725-9. PubMed ID: 18256672
[TBL] [Abstract][Full Text] [Related]
3. CpG DNA stimulates autoreactive immature B cells in the bone marrow.
Azulay-Debby H; Edry E; Melamed D
Eur J Immunol; 2007 Jun; 37(6):1463-75. PubMed ID: 17474151
[TBL] [Abstract][Full Text] [Related]
4. B lymphocytes as direct antigen-presenting cells for anti-tumor DNA vaccines.
Colluru VT; McNeel DG
Oncotarget; 2016 Oct; 7(42):67901-67918. PubMed ID: 27661128
[TBL] [Abstract][Full Text] [Related]
5. Vaccination with liposome--DNA complexes elicits enhanced antitumor immunity.
U'Ren L; Kedl R; Dow S
Cancer Gene Ther; 2006 Nov; 13(11):1033-44. PubMed ID: 16841080
[TBL] [Abstract][Full Text] [Related]
6. B cells as antigen presenting cells.
Rodríguez-Pinto D
Cell Immunol; 2005 Dec; 238(2):67-75. PubMed ID: 16574086
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor-dependent activation of antigen-presenting cells affects adaptive immunity to Helicobacter pylori.
Rad R; Brenner L; Krug A; Voland P; Mages J; Lang R; Schwendy S; Reindl W; Dossumbekova A; Ballhorn W; Wagner H; Schmid RM; Bauer S; Prinz C
Gastroenterology; 2007 Jul; 133(1):150-163.e3. PubMed ID: 17631139
[TBL] [Abstract][Full Text] [Related]
8. Engineering enhancement of the immune response to HBV DNA vaccine in mice by the use of LIGHT gene adjuvant.
Zhang Y; Jiang W; Fan Y; Wen J; Hao W; Qian M
J Virol Methods; 2008 Nov; 153(2):142-8. PubMed ID: 18722475
[TBL] [Abstract][Full Text] [Related]
9. In vitro assay of immunostimulatory activities of plasmid vectors.
Jiang W; Reich CF; Pisetsky DS
Methods Mol Med; 2006; 127():55-70. PubMed ID: 16988446
[TBL] [Abstract][Full Text] [Related]
10. DNA and RNA autoantigens as autoadjuvants.
Busconi L; Lau CM; Tabor AS; Uccellini MB; Ruhe Z; Akira S; Viglianti GA; Rifkin IR; Marshak-Rothstein A
J Endotoxin Res; 2006; 12(6):379-84. PubMed ID: 17254393
[TBL] [Abstract][Full Text] [Related]
11. Targeting plasmid-encoded proteins to the antigen presentation pathways.
Leifert JA; Rodriguez-Carreno MP; Rodriguez F; Whitton JL
Immunol Rev; 2004 Jun; 199():40-53. PubMed ID: 15233725
[TBL] [Abstract][Full Text] [Related]
12. TLR9 stimulation drives naïve B cells to proliferate and to attain enhanced antigen presenting function.
Jiang W; Lederman MM; Harding CV; Rodriguez B; Mohner RJ; Sieg SF
Eur J Immunol; 2007 Aug; 37(8):2205-13. PubMed ID: 17621369
[TBL] [Abstract][Full Text] [Related]
13. TOLL-like receptor ligands stimulate aberrant class switch recombination in early B cell precursors.
Edry E; Azulay-Debby H; Melamed D
Int Immunol; 2008 Dec; 20(12):1575-85. PubMed ID: 18974086
[TBL] [Abstract][Full Text] [Related]
14. Co-immunisation with DNA encoding RANK/RANKL or 4-1BBL costimulatory molecules does not enhance effector or memory CTL responses afforded by immunisation with a tumour antigen-encoding DNA vaccine.
Herd KA; Wiethe C; Tindle RW
Vaccine; 2007 Jul; 25(28):5209-19. PubMed ID: 17544551
[TBL] [Abstract][Full Text] [Related]
15. Vaccination with a DNA vaccine based on human PSCA and HSP70 adjuvant enhances the antigen-specific CD8+ T-cell response and inhibits the PSCA+ tumors growth in mice.
Zhang X; Yu C; Zhao J; Fu L; Yi S; Liu S; Yu T; Chen W
J Gene Med; 2007 Aug; 9(8):715-26. PubMed ID: 17595048
[TBL] [Abstract][Full Text] [Related]
16. IFN-alpha amplifies human naive B cell TLR-9-mediated activation and Ig production.
Giordani L; Sanchez M; Libri I; Quaranta MG; Mattioli B; Viora M
J Leukoc Biol; 2009 Aug; 86(2):261-71. PubMed ID: 19401392
[TBL] [Abstract][Full Text] [Related]
17. Decreased suppression of immune stimulatory CpG motifs in plant DNA.
Wang Y; Zhou J; Liu B
Immunol Lett; 2007 Dec; 114(2):73-80. PubMed ID: 17889375
[TBL] [Abstract][Full Text] [Related]
18. Are B lymphocytes the principal antigen-presenting cells in vivo?
Ashwell JD
J Immunol; 1988 Jun; 140(11):3697-700. PubMed ID: 3286762
[No Abstract] [Full Text] [Related]
19. Effect of synthetic agonists of toll-like receptor 9 on canine lymphocyte proliferation and cytokine production in vitro.
Im Hof M; Williamson L; Summerfield A; Balmer V; Dutoit V; Kandimalla ER; Yu D; Zurbriggen A; Doherr MG; Peel J; Roosje PJ
Vet Immunol Immunopathol; 2008 Jul; 124(1-2):120-31. PubMed ID: 18452997
[TBL] [Abstract][Full Text] [Related]
20. Antigen presentation and transfer between B cells and macrophages.
Harvey BP; Gee RJ; Haberman AM; Shlomchik MJ; Mamula MJ
Eur J Immunol; 2007 Jul; 37(7):1739-51. PubMed ID: 17534863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
